Articles written by Benzinga Newdesk

AcelRx Pharmaceuticals Announces 20-For-1 Reverse Stock Split Effective Tomorrow, Oct. 26

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced

The Bear Cave Issues Short Report Titled 'Problems at ZoomInfo Technologies (ZI)'

https://thebearcave.substack.com/p/problems-at-zoominfo-technologies?s=r

Goldman Sachs Says Don't Expect 2022 To Look Like 2021, Especially As Monetary Policy Tightens And Fiscal Policy Becomes Less Supportive